Related Experiment Video
Updated: Jul 10, 2026

Intra-lymph Node Injection of Biodegradable Polymer Particles
Published on: January 2, 2014
Delivery systems for immunomodulatory proteins and peptides
1Department of Pediatrics and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Drug delivery systems enhance the effectiveness of protein and polypeptide immunomodulators. Various carriers, including liposomes and engineered cells, improve immune system interactions and therapeutic outcomes.
Area of Science:
- Immunology
- Biotechnology
- Drug Delivery Systems
Background:
- Polypeptide and protein immunomodulators face challenges with absorption, biodistribution, metabolism, and degradation, limiting their effectiveness.
- Drug carrier technology offers solutions to overcome these limitations and improve therapeutic interactions.
Purpose of the Study:
- To explore various drug delivery systems for enhancing the immunomodulatory potential of polypeptides and proteins.
- To review methods for improving the delivery and efficacy of immunomodulatory agents.
Main Methods:
- Utilizing liposomes to increase delivery of immunomodulators to lymphatic tissues and macrophages.
- Employing polypeptides for enhanced immunostimulation, oral delivery, and depot effects.
- Investigating biodegradable carriers like polysaccharide microspheres.
- Developing genetically engineered bacteria, viruses, and mammalian cells as delivery vehicles.
- Using attenuated Salmonella strains for targeted delivery to lymphoid tissues, liver, and spleen.
- Employing tumor cells engineered to produce granulocyte-macrophage colony-stimulating factor (GM-CSF) to elicit immune responses.
Main Results:
- Liposome-associated Interleukin-2 (IL-2) demonstrates reduced toxicity and enhanced immunotherapeutic effects in preclinical models and human trials.
- Aerosol delivery of liposomal immunomodulators is effective for lung targeting.
- Polysaccharide microspheres serve as effective biodegradable carriers.
- Genetically engineered bacteria and cells successfully deliver immunomodulators to specific tissues.
- GM-CSF-producing tumor cells induce potent cell-mediated immune responses, including tumor elimination and memory responses.
Conclusions:
- Drug delivery systems significantly enhance the immunomodulatory potential of polypeptides and proteins.
- Liposomes, engineered cells, and microspheres are promising platforms for immunomodulator delivery.
- Targeted delivery strategies can improve therapeutic efficacy and reduce toxicity of immunomodulatory agents.
Related Concept Videos
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Modified-Release Drug Delivery Systems: Site-Targeted
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Routes of Drug Administration: Parenteral
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
Drug Delivery Systems: Different Types

